APO Research
Talk to an analyst

APO RESEARCH · REPORT

Felbamate

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Felbamate Industry Growth and Trends Forecast to 2032

20 December 202590 pages

Choose your research edition.

Industry ResearchFelbamate Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Felbamate Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Felbamate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Felbamate Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Felbamate Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Felbamate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Felbamate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Felbamate is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Felbamate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Felbamate include Sun Pharma, Mylan, Schering Plough, Merck Sharp and Dohme, Corepharma, Cadila Healthcare, ANI Pharmaceuticals, Amneal Pharmaceuticals and Alvogen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Felbamate market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Felbamate market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Felbamate market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Felbamate.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Felbamate market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Felbamate Market by Company

Sun Pharma

Mylan

Schering Plough

Merck Sharp and Dohme

Corepharma

Cadila Healthcare

ANI Pharmaceuticals

Amneal Pharmaceuticals

Alvogen

Felbamate Segment by Type

Tablet

Oral Solution

Felbamate Segment by Application

Refractory Lennox-Gastaut Syndrome

Refractory Seizure Disorders

Others

Felbamate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Felbamate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Felbamate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Felbamate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Felbamate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Felbamate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablet Table 2. Major Company of Oral Solution Table 3. Global Felbamate Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Felbamate Sales by Type (2021-2026) & (K Units) Table 5. Global Felbamate Sales Market Share in Volume by Type (2021-2026) Table 6. Global Felbamate Sales by Type (2021-2026) & (US$ Million) Table 7. Global Felbamate Sales Market Share in Value by Type (2021-2026) Table 8. Global Felbamate Price by Type (2021-2026) & (US$/Unit) Table 9. Global Felbamate Sales by Type (2027-2032) & (K Units) Table 10. Global Felbamate Sales Market Share in Volume by Type (2027-2032) Table 11. Global Felbamate Sales by Type (2027-2032) & (US$ Million) Table 12. Global Felbamate Sales Market Share in Value by Type (2027-2032) Table 13. Global Felbamate Price by Type (2027-2032) & (US$/Unit) Table 14. North America Felbamate Sales by Type (2021-2026) & (K Units) Table 15. North America Felbamate Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Felbamate Sales by Type (2021-2026) & (K Units) Table 17. Europe Felbamate Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Felbamate Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Felbamate Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Felbamate Sales by Type (2021-2026) & (K Units) Table 21. Latin America Felbamate Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Felbamate Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Felbamate Sales by Type (2021-2026) & (US$ Million) Table 24. Felbamate Industry Trends Table 25. Felbamate Industry Drivers Table 26. Felbamate Industry Opportunities and Challenges Table 27. Felbamate Industry Restraints Table 28. Global Felbamate Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Felbamate Revenue Market Share by Company (2021-2026) Table 30. Global Felbamate Sales by Company (2021-2026) & (K Units) Table 31. Global Felbamate Sales Share by Company (2021-2026) Table 32. Global Felbamate Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Felbamate Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Felbamate Major Company Production Sites and Headquarters Table 35. Global Felbamate Company, Product Type & Application Table 36. Global Felbamate Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Felbamate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Felbamate Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Felbamate Sales by Region (2021-2026) & (K Units) Table 41. Global Felbamate Sales Market Share in Volume by Region (2021-2026) Table 42. Global Felbamate Sales by Region (2021-2026) & (US$ Million) Table 43. Global Felbamate Sales Market Share in Value by Region (2021-2026) Table 44. Global Felbamate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Felbamate Sales by Region (2027-2032) & (K Units) Table 46. Global Felbamate Sales Market Share in Volume by Region (2027-2032) Table 47. Global Felbamate Sales by Region (2027-2032) & (US$ Million) Table 48. Global Felbamate Sales Market Share in Value by Region (2027-2032) Table 49. Global Felbamate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Felbamate Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Felbamate Sales by Application (2021-2026) & (K Units) Table 52. Global Felbamate Sales Market Share in Volume by Application (2021-2026) Table 53. Global Felbamate Sales by Application (2021-2026) & (US$ Million) Table 54. Global Felbamate Sales Market Share in Value by Application (2021-2026) Table 55. Global Felbamate Price by Application (2021-2026) & (US$/Unit) Table 56. Global Felbamate Sales by Application (2027-2032) & (K Units) Table 57. Global Felbamate Sales Market Share in Volume by Application (2027-2032) Table 58. Global Felbamate Sales by Application (2027-2032) & (US$ Million) Table 59. Global Felbamate Sales Market Share in Value by Application (2027-2032) Table 60. Global Felbamate Price by Application (2027-2032) & (US$/Unit) Table 61. North America Felbamate Sales by Application (2021-2026) & (K Units) Table 62. North America Felbamate Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Felbamate Sales by Application (2021-2026) & (K Units) Table 64. Europe Felbamate Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Felbamate Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Felbamate Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Felbamate Sales by Application (2021-2026) & (K Units) Table 68. Latin America Felbamate Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Felbamate Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Felbamate Sales by Application (2021-2026) & (US$ Million) Table 71. Sun Pharma Company Information Table 72. Sun Pharma Business Overview Table 73. Sun Pharma Felbamate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Sun Pharma Felbamate Product Portfolio Table 75. Sun Pharma Recent Development Table 76. Mylan Company Information Table 77. Mylan Business Overview Table 78. Mylan Felbamate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Mylan Felbamate Product Portfolio Table 80. Mylan Recent Development Table 81. Schering Plough Company Information Table 82. Schering Plough Business Overview Table 83. Schering Plough Felbamate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Schering Plough Felbamate Product Portfolio Table 85. Schering Plough Recent Development Table 86. Merck Sharp and Dohme Company Information Table 87. Merck Sharp and Dohme Business Overview Table 88. Merck Sharp and Dohme Felbamate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Merck Sharp and Dohme Felbamate Product Portfolio Table 90. Merck Sharp and Dohme Recent Development Table 91. Corepharma Company Information Table 92. Corepharma Business Overview Table 93. Corepharma Felbamate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Corepharma Felbamate Product Portfolio Table 95. Corepharma Recent Development Table 96. Cadila Healthcare Company Information Table 97. Cadila Healthcare Business Overview Table 98. Cadila Healthcare Felbamate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Cadila Healthcare Felbamate Product Portfolio Table 100. Cadila Healthcare Recent Development Table 101. ANI Pharmaceuticals Company Information Table 102. ANI Pharmaceuticals Business Overview Table 103. ANI Pharmaceuticals Felbamate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. ANI Pharmaceuticals Felbamate Product Portfolio Table 105. ANI Pharmaceuticals Recent Development Table 106. Amneal Pharmaceuticals Company Information Table 107. Amneal Pharmaceuticals Business Overview Table 108. Amneal Pharmaceuticals Felbamate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Amneal Pharmaceuticals Felbamate Product Portfolio Table 110. Amneal Pharmaceuticals Recent Development Table 111. Alvogen Company Information Table 112. Alvogen Business Overview Table 113. Alvogen Felbamate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Alvogen Felbamate Product Portfolio Table 115. Alvogen Recent Development Table 116. North America Felbamate Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. North America Felbamate Sales by Country (2021-2026) & (K Units) Table 118. North America Felbamate Sales Market Share by Country (2021-2026) Table 119. North America Felbamate Sales Forecast by Country (2027-2032) & (K Units) Table 120. North America Felbamate Sales Market Share Forecast by Country (2027-2032) Table 121. North America Felbamate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Felbamate Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Felbamate Market Share by Country (2021-2026) Table 124. North America Felbamate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Felbamate Market Share Forecast by Country (2027-2032) Table 126. Europe Felbamate Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Europe Felbamate Sales by Country (2021-2026) & (K Units) Table 128. Europe Felbamate Sales Market Share by Country (2021-2026) Table 129. Europe Felbamate Sales Forecast by Country (2027-2032) & (K Units) Table 130. Europe Felbamate Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Felbamate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Felbamate Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Felbamate Market Share by Country (2021-2026) Table 134. Europe Felbamate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Felbamate Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Felbamate Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Felbamate Sales by Country (2021-2026) & (K Units) Table 138. Asia-Pacific Felbamate Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Felbamate Sales Forecast by Country (2027-2032) & (K Units) Table 140. Asia-Pacific Felbamate Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Felbamate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Felbamate Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Felbamate Market Share by Country (2021-2026) Table 144. Asia-Pacific Felbamate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Felbamate Market Share Forecast by Country (2027-2032) Table 146. Latin America Felbamate Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Latin America Felbamate Sales by Country (2021-2026) & (K Units) Table 148. Latin America Felbamate Sales Market Share by Country (2021-2026) Table 149. Latin America Felbamate Sales Forecast by Country (2027-2032) & (K Units) Table 150. Latin America Felbamate Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Felbamate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Felbamate Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Felbamate Market Share by Country (2021-2026) Table 154. Latin America Felbamate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Felbamate Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Felbamate Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Felbamate Sales by Country (2021-2026) & (K Units) Table 158. Middle East and Africa Felbamate Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Felbamate Sales Forecast by Country (2027-2032) & (K Units) Table 160. Middle East and Africa Felbamate Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Felbamate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Felbamate Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Felbamate Market Share by Country (2021-2026) Table 164. Middle East and Africa Felbamate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Felbamate Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Felbamate Distributors List Table 169. Felbamate Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Felbamate Image Figure 2. Global Felbamate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Felbamate Market Size (2021-2032) & (US$ Million) Figure 4. Global Felbamate Sales (2021-2032) & (K Units) Figure 5. Tablet Image Figure 6. Global Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 7. Oral Solution Image Figure 8. Global Oral Solution Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Felbamate Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Felbamate Market Share by Type 2025 VS 2032 Figure 11. North America Felbamate Sales Market Share in Volume by Type in 2025 Figure 12. North America Felbamate Sales Market Share in Value by Type in 2025 Figure 13. Europe Felbamate Sales Market Share in Volume by Type in 2025 Figure 14. Europe Felbamate Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Felbamate Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Felbamate Sales Market Share in Value by Type in 2025 Figure 17. Latin America Felbamate Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Felbamate Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Felbamate Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Felbamate Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Felbamate Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Refractory Lennox-Gastaut Syndrome Image Figure 24. Global Refractory Lennox-Gastaut Syndrome Sales YoY Growth (2021-2032) & (K Units) Figure 25. Refractory Seizure Disorders Image Figure 26. Global Refractory Seizure Disorders Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Felbamate Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Felbamate Market Share by Application 2025 VS 2032 Figure 31. North America Felbamate Sales Market Share in Volume by Application in 2025 Figure 32. North America Felbamate Sales Market Share in Value by Application in 2025 Figure 33. Europe Felbamate Sales Market Share in Volume by Application in 2025 Figure 34. Europe Felbamate Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Felbamate Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Felbamate Sales Market Share in Value by Application in 2025 Figure 37. Latin America Felbamate Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Felbamate Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Felbamate Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Felbamate Sales Market Share in Value by Application in 2025 Figure 41. North America Felbamate Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Felbamate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Felbamate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Felbamate Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Felbamate Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Felbamate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Felbamate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Felbamate Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Felbamate Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Felbamate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Felbamate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Felbamate Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Felbamate Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Felbamate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Felbamate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Felbamate Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Felbamate Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Felbamate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Felbamate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Felbamate Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Felbamate Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Felbamate Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Oral Solution
Applications
  • Refractory Lennox-Gastaut Syndrome
  • Refractory Seizure Disorders
  • Others
Companies covered
  • Sun Pharma
  • Mylan
  • Schering Plough
  • Merck Sharp and Dohme
  • Corepharma
  • Cadila Healthcare
  • ANI Pharmaceuticals
  • Amneal Pharmaceuticals
  • Alvogen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Felbamate Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Felbamate Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Felbamate Market by Type
  6. 1.3.1 Tablet
  7. 1.3.2 Oral Solution
  8. 1.4 Global Felbamate Market Size by Type
  9. 1.4.1 Global Felbamate Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Felbamate Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Felbamate Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Felbamate Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Felbamate Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Felbamate Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Felbamate Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Felbamate Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Felbamate Industry Trends
  2. 2.2 Felbamate Industry Drivers
  3. 2.3 Felbamate Industry Opportunities and Challenges
  4. 2.4 Felbamate Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Felbamate Revenue (2021-2026)
  2. 3.2 Global Top Players by Felbamate Sales (2021-2026)
  3. 3.3 Global Top Players by Felbamate Price (2021-2026)
  4. 3.4 Global Felbamate Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Felbamate Major Company Production Sites & Headquarters
  6. 3.6 Global Felbamate Company, Product Type & Application
  7. 3.7 Global Felbamate Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Felbamate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Felbamate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Felbamate Tier 1, Tier 2, and Tier 3
4 Felbamate Regional Status and Outlook
  1. 4.1 Global Felbamate Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Felbamate Historic Market Size by Region
  3. 4.2.1 Global Felbamate Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Felbamate Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Felbamate Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Felbamate Forecasted Market Size by Region
  7. 4.3.1 Global Felbamate Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Felbamate Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Felbamate Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Felbamate by Application
  1. 5.1 Felbamate Market by Application
  2. 5.1.1 Refractory Lennox-Gastaut Syndrome
  3. 5.1.2 Refractory Seizure Disorders
  4. 5.1.3 Others
  5. 5.2 Global Felbamate Market Size by Application
  6. 5.2.1 Global Felbamate Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Felbamate Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Felbamate Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Felbamate Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Felbamate Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Felbamate Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Felbamate Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Felbamate Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sun Pharma
  2. 6.1.1 Sun Pharma Company Information
  3. 6.1.2 Sun Pharma Business Overview
  4. 6.1.3 Sun Pharma Felbamate Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sun Pharma Felbamate Product Portfolio
  6. 6.1.5 Sun Pharma Recent Developments
  7. 6.2 Mylan
  8. 6.2.1 Mylan Company Information
  9. 6.2.2 Mylan Business Overview
  10. 6.2.3 Mylan Felbamate Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mylan Felbamate Product Portfolio
  12. 6.2.5 Mylan Recent Developments
  13. 6.3 Schering Plough
  14. 6.3.1 Schering Plough Company Information
  15. 6.3.2 Schering Plough Business Overview
  16. 6.3.3 Schering Plough Felbamate Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Schering Plough Felbamate Product Portfolio
  18. 6.3.5 Schering Plough Recent Developments
  19. 6.4 Merck Sharp and Dohme
  20. 6.4.1 Merck Sharp and Dohme Company Information
  21. 6.4.2 Merck Sharp and Dohme Business Overview
  22. 6.4.3 Merck Sharp and Dohme Felbamate Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck Sharp and Dohme Felbamate Product Portfolio
  24. 6.4.5 Merck Sharp and Dohme Recent Developments
  25. 6.5 Corepharma
  26. 6.5.1 Corepharma Company Information
  27. 6.5.2 Corepharma Business Overview
  28. 6.5.3 Corepharma Felbamate Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Corepharma Felbamate Product Portfolio
  30. 6.5.5 Corepharma Recent Developments
  31. 6.6 Cadila Healthcare
  32. 6.6.1 Cadila Healthcare Company Information
  33. 6.6.2 Cadila Healthcare Business Overview
  34. 6.6.3 Cadila Healthcare Felbamate Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Cadila Healthcare Felbamate Product Portfolio
  36. 6.6.5 Cadila Healthcare Recent Developments
  37. 6.7 ANI Pharmaceuticals
  38. 6.7.1 ANI Pharmaceuticals Company Information
  39. 6.7.2 ANI Pharmaceuticals Business Overview
  40. 6.7.3 ANI Pharmaceuticals Felbamate Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 ANI Pharmaceuticals Felbamate Product Portfolio
  42. 6.7.5 ANI Pharmaceuticals Recent Developments
  43. 6.8 Amneal Pharmaceuticals
  44. 6.8.1 Amneal Pharmaceuticals Company Information
  45. 6.8.2 Amneal Pharmaceuticals Business Overview
  46. 6.8.3 Amneal Pharmaceuticals Felbamate Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Amneal Pharmaceuticals Felbamate Product Portfolio
  48. 6.8.5 Amneal Pharmaceuticals Recent Developments
  49. 6.9 Alvogen
  50. 6.9.1 Alvogen Company Information
  51. 6.9.2 Alvogen Business Overview
  52. 6.9.3 Alvogen Felbamate Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Alvogen Felbamate Product Portfolio
  54. 6.9.5 Alvogen Recent Developments
7 North America by Country
  1. 7.1 North America Felbamate Sales by Country
  2. 7.1.1 North America Felbamate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Felbamate Sales by Country (2021-2026)
  4. 7.1.3 North America Felbamate Sales Forecast by Country (2027-2032)
  5. 7.2 North America Felbamate Market Size by Country
  6. 7.2.1 North America Felbamate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Felbamate Market Size by Country (2021-2026)
  8. 7.2.3 North America Felbamate Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Felbamate Sales by Country
  2. 8.1.1 Europe Felbamate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Felbamate Sales by Country (2021-2026)
  4. 8.1.3 Europe Felbamate Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Felbamate Market Size by Country
  6. 8.2.1 Europe Felbamate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Felbamate Market Size by Country (2021-2026)
  8. 8.2.3 Europe Felbamate Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Felbamate Sales by Country
  2. 9.1.1 Asia-Pacific Felbamate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Felbamate Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Felbamate Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Felbamate Market Size by Country
  6. 9.2.1 Asia-Pacific Felbamate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Felbamate Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Felbamate Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Felbamate Sales by Country
  2. 10.1.1 South America Felbamate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Felbamate Sales by Country (2021-2026)
  4. 10.1.3 South America Felbamate Sales Forecast by Country (2027-2032)
  5. 10.2 South America Felbamate Market Size by Country
  6. 10.2.1 South America Felbamate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Felbamate Market Size by Country (2021-2026)
  8. 10.2.3 South America Felbamate Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Felbamate Sales by Country
  2. 11.1.1 Middle East and Africa Felbamate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Felbamate Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Felbamate Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Felbamate Market Size by Country
  6. 11.2.1 Middle East and Africa Felbamate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Felbamate Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Felbamate Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Felbamate Value Chain Analysis
  2. 12.1.1 Felbamate Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Felbamate Production Mode & Process
  7. 12.2 Felbamate Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Felbamate Distributors
  10. 12.2.3 Felbamate Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst